Circ_0011058 alleviates RA pathology through the circ_0011058/miR-335-5p/CUL4B signal axis

Author:

Wang Xiaomei1,Xue Qiuyun2,Duan Qiangjun3,Sun Ziyi4,Wu Yajie2,Yang Shuo56,Xu Pengfei56,Cao Huibo7,Liao Faxue56,Wang Xiao8,Miao Chenggui29

Affiliation:

1. Department of Humanistic Nursing, School of Nursing, Anhui University of Chinese Medicine, Hefei, China

2. Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China

3. Department of Experimental Teaching Center, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China

4. Department of Scientific Research Technology Center, Anhui University of Chinese Medicine, Hefei, China

5. Department of Orthopaedics, the First Affiliated Hospital of Anhui Medical University, Hefei, China

6. Anhui Public Health Clinical Center, Hefei, China

7. Chuzhou Integrated Traditional Chinese and Western Medicine Hospital, Anhui University of Chinese Medicine, Chuzhou, China

8. Department of Clinical Nursing, School of Nursing, Anhui University of Chinese Medicine, Hefei, China

9. Institute of Rheumatism, Anhui University of Chinese Medicine, Hefei, China

Funder

Anhui University of Chinese Medicine

National Natural Science Foundation of China

Anhui Science and Technology Department

Anhui Education Department

Anhui University of Chinese medicine

Anhui Administration of Traditional Chinese Medicine

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis;Lin YJ;Cells,2020

2. The etiology of rheumatoid arthritis;Scherer HU;J Autoimmun,2020

3. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management;Dai Y;Clin Rheumatol,2021

4. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift;Deane KD;Arthritis Rheumatol,2021

5. circRNA-miRNA-mRNA in breast cancer;Zhang M;Clin Chim Acta,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3